成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 30827-99-7 Chemical Structure| 30827-99-7
Chemical Structure| 30827-99-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 30827-99-7

,{[proInfo.pro_purity]}

AEBSF HCl is a irreversible inhibitor of proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.

Synonyms: AEBSF (hydrochloride); AEBSF HCl; Pefabloc SC

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of AEBSF HCl

CAS No. :30827-99-7
Formula : C8H11ClFNO2S
M.W : 239.69
SMILES Code : O=S(C1=CC=C(CCN)C=C1)(F)=O.[H]Cl
Synonyms :
AEBSF (hydrochloride); AEBSF HCl; Pefabloc SC
InChI Key :WRDABNWSWOHGMS-UHFFFAOYSA-N
Pubchem ID :186136

Safety of AEBSF HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H314
Precautionary Statements:P260-P280-P303+P361+P353-P301+P330+P331-P304+P340+P310-P305+P351+P338+P310
Class:8
UN#:3261
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
Neutrophils 1 mM 1 hour Inhibition of IL-1β secretion PMC5825906
human umbilical vein endothelial cells (HUVEC) 1 mg/ml 1 hour Evaluate the uptake of PG-AF in HUVEC, showing that PG-AF accumulates in cells while free AF does not. PMC5245978
human plasma 100 μg/mL 120 seconds To assess the effect of AEBSF on the direct fibrinogen cleaving actions of C. mictlantecuhtli venom, results showed that AEBSF inhibited this action. PMC8011430
Mono Mac 6 (MM6) cells 150 to 250 μM 18 hours AEBSF blocked Dicer proteolysis, resulting in increased full-length Dicer and decreased 170 kDa and 50 kDa fragments. PMC7165444
human primary monocytes 250 μM 18 hours AEBSF treatment resulted in strong up-regulation of full-length Dicer and reduced the 50 kDa fragment. PMC7165444
human retinal pigment epithelial cells (hRPE) 0-300 μM 2 hours Pretreatment with AEBSF significantly inhibited TM-induced mitochondrial permeability transition and cell death in hRPE cells PMC3454510
keratinocytes 250 μM 20 hours AEBSF significantly inhibited TLSP activity in the stratum corneum. PMC4169281
Uni-Graft prosthesis 0.6 mg/mL 3 hours Inhibition of adhesion and multiplication of Staphylococcus aureus and Candida albicans PMC7023003
Human Umbilical Vein Endothelial Cells (HUVEC) 100 μM 4 hours AEBSF inhibited the ATF6 signaling pathway, blocking the sFRP2-mediated angiogenesis through cTGF, resulting in reduced tubule formation in HUVECs. PMC8530433

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
sFRP2 TG mice Permanent Coronary Artery Occlusion Model Osmotic Pump 2 μg/kg/day Once daily for 1 week AEBSF, by inhibiting the ATF6 signaling pathway, blocked the sFRP2-mediated cardioprotection and angiogenesis, resulting in the abolition of reduced infarct size and protection of cardiac function. PMC8530433
Mice IL10-/- mice Oral gavage 300 mg/kg body weight Starting from 1 day before V/M treatment and continuing during V/M treatment To assess the effect of AEBSF on V/M-induced high protease activity and intestinal barrier function, results showed that AEBSF significantly reduced protease activity and protected intestinal barrier function. PMC6121113

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.17mL

0.83mL

0.42mL

20.86mL

4.17mL

2.09mL

41.72mL

8.34mL

4.17mL

References

 

Historical Records

Categories